Replies to post #87821 on Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

Far as I can tell, they have one cell therapy in their pipeline now, which is a small CAR-T program in phase 1 being developed in house.

Clearly, cell therapy is not a high priority for them. That does NOT make this good news or anything, other than to say they may not have been the right partner after all. For now, we suffer the paper loss